Back
ZyVersa Therapeutics, Inc. Stock Predictions
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
65
ZVSA
ZyVersa Therapeutics, Inc.
Last Price:
$0.27
Seasonality Move:
-20.68%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atZyVersa Therapeutics, Inc. Stock Forecast
-
Is ZyVersa Therapeutics, Inc. Stock Undervalued?The current ZyVersa Therapeutics, Inc. [ZVSA] share price is $0.27. The Score for ZVSA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ZVSA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will ZyVersa Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
ZyVersa Therapeutics, Inc. Stock Rating
Data Unavailable
ZyVersa Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
zyversa.com
52-Week Data
52-Week High:
1.95
52-Week Low:
0.11
Prediction Charts
Market Cap:
2.1M
Price in USD:
0.27
Volume:
1.5M
Beta:
1.04
Technical Analysis
SMA50:
0.14
SMA100:
0.15
SMA200:
0.35
52-Wk Change:
-77.53%
Stock Predictions
-
Is ZyVersa Therapeutics, Inc. stock public?Yes, ZyVersa Therapeutics, Inc. is a publicly traded company.
-
What is the ZyVersa Therapeutics, Inc. stock quote today?The ZyVersa Therapeutics, Inc. stock price is 0.27 USD today.
-
How to buy ZyVersa Therapeutics, Inc. stock online?You can buy ZyVersa Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-17 | 0.13 | 0.14 | 0.15 | 0.13 |
| Dec-18 | 0.13 | 0.14 | 0.15 | 0.13 |
| Dec-19 | 0.14 | 0.14 | 0.14 | 0.14 |
| Dec-22 | 0.14 | 0.13 | 0.14 | 0.13 |
| Dec-24 | 0.13 | 0.13 | 0.15 | 0.13 |
| Dec-26 | 0.13 | 0.13 | 0.14 | 0.13 |
| Dec-29 | 0.13 | 0.13 | 0.14 | 0.13 |
| Dec-30 | 0.13 | 0.13 | 0.13 | 0.13 |
| Dec-31 | 0.13 | 0.13 | 0.13 | 0.13 |
| Jan-5 | 0.13 | 0.13 | 0.13 | 0.13 |
| Jan-6 | 0.13 | 0.13 | 0.13 | 0.13 |
| Jan-7 | 0.13 | 0.15 | 0.15 | 0.13 |
| Jan-8 | 0.15 | 0.16 | 0.18 | 0.15 |
| Jan-9 | 0.17 | 0.27 | 0.27 | 0.17 |
ZyVersa Therapeutics, Inc. Earnings
Data Unavailable
ZyVersa Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
* ZyVersa Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.